DEF 14A: National HealthCare Corporation Announces 2024 Annual Meeting of Shareholders
Proxy Statement
National HealthCare Corporation (NHC) will hold its 2024 Annual Meeting of Shareholders on May 9, 2024, to vote on director re-elections and executive compensation.
Summary
- National HealthCare Corporation (NHC) is holding its 2024 Annual Meeting of Shareholders on May 9, 2024, in Murfreesboro, Tennessee.
- Shareholders will vote on the re-election of J. Paul Abernathy, M.D. and Robert G. Adams as directors for three-year terms.
- An advisory vote on the compensation of NHC's Named Executive Officers will also take place.
- The record date for determining shareholders eligible to vote is March 12, 2024.
- Shareholders can vote by telephone, online, or by mail.
- The Board of Directors recommends voting FOR the re-election of the director nominees and FOR the approval of the executive compensation.
- As of March 12, 2024, there were 15,396,850 shares of Common Stock outstanding.
- BlackRock, Inc. beneficially owns 14.0% of the Common Stock, and The Vanguard Group owns 9.9%.
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, which is generally neutral in tone. It provides necessary information for shareholders to make informed decisions. The positive aspects include the company's commitment to diversity and sustainability, while the risks are acknowledged but not emphasized.
Positives
- The Board is committed to diversity, including race, ethnicity, gender, and age, when evaluating Board candidates.
- NHC supports a workplace culture that values diversity and promotes inclusion.
- The company has a long history of investing in the communities where they operate through the National Health Foundation and The Foundation for Geriatric Education.
- The company has a Compassion Fund to support partners in times of need.
- NHC is committed to minimizing its effect on the environment by conserving energy and protecting natural resources.
- The Board has adopted a policy that prohibits officers and directors from hedging against decreases in the market value of NHC's equity securities.
Risks
- The document mentions the importance of cyber security and the company's efforts to guard against cyber security threats and comply with SEC regulations.
- The document mentions the COVID-19 pandemic and the company's response to ensure the safety of its partners, indicating potential risks associated with public health emergencies.
Future Outlook
The document outlines the matters to be addressed at the upcoming annual meeting and provides information relevant to shareholder voting. It does not contain specific forward-looking statements about the company's future financial performance or strategic direction beyond the standard business to be conducted at the meeting.
Management Comments
- Robert G. Adams, Chairman of the Board, and Stephen F. Flatt, Chief Executive Officer, invite shareholders to attend the Annual Meeting and emphasize the importance of their vote.
- The Board believes that having separate Chairman and CEO positions is currently the best governance model for the Company and its shareholders.
Industry Context
This document is a standard proxy statement related to corporate governance and shareholder voting, common among publicly traded companies in the healthcare sector. It provides transparency and allows shareholders to participate in key decisions regarding the company's leadership and compensation practices.
Comparison to Industry Standards
- The document outlines standard corporate governance practices, such as the election of directors, executive compensation, and related party transactions, which are typical for publicly traded companies like National HealthCare Corporation.
- The company's compensation policies, including base salary, bonus compensation, and equity-based compensation, are designed to align with industry standards and incentivize performance.
- The document mentions that the Board annually reviews its total compensation package in light of compensation paid to directors of comparable health care companies, indicating a commitment to benchmarking against industry peers.
- The company's related party transaction policies and procedures are consistent with regulatory requirements and aim to ensure transparency and fairness in dealings with related parties.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Diversity | The Board has taken steps to address Board diversity, including considering race, gender, ethnicity, and age when evaluating Board candidates and Board composition. | August 15, 2020 | The Amended and Restated Nominating and Corporate Governance Committee Charter and Corporate Governance Guidelines are posted on the Company website. |
| Insider Trading Policy | The Board of Directors adopted a new NHC Insider Trading Policy. | November 2, 2023 | The Company has adopted policies and procedures designed to prohibit unlawful trading, hedging transactions and related practices. |
| Compensation Recoupment Policy | The Board of Directors adopted a Compensation Recoupment Clawback Policy. | November 2, 2023 | A copy of the policy is filed as an exhibit to the Company's 2023 10-K. |
Related Party Transactions
- NHC employs four persons who are immediate family members of directors and/or executive officers who receive in excess of $120,000 in compensation.
- NHC leases real property from National Health Investors, Inc. (NHI), and Mr. Robert G. Adams and Mr. W. Andrew Adams are both directors of NHI as well as NHC.
- National Health Corporation (National), which is wholly-owned by the National Health Corporation Leveraged Employee Stock Ownership Plan (ESOP), is NHC's administrative services affiliate and contractor.
Stakeholder Impact
- Shareholders are provided with information to make informed decisions regarding director elections and executive compensation.
- Employees (Partners) are recognized as the single most important element in the company's success, and compensation programs are designed to be similar for all Partners.
- The company's commitment to sustainability and community investment benefits the communities in which it operates.
- The company's focus on cyber security and compliance with regulations protects stakeholders from potential risks.
Next Steps
- Shareholders are encouraged to vote on the proposals outlined in the proxy statement before the Annual Meeting on May 9, 2024.
- The company will announce preliminary or final voting results at the Meeting and publish final results in a Current Report on Form 8-K filed with the Securities and Exchange Commission (the SEC) within four business days of the completion of the Meeting.
Key Dates
| Date | Description |
|---|---|
| March 12, 2024 | Record date for determining shareholders eligible to vote at the Annual Meeting. |
| May 9, 2024 | Date of the 2024 Annual Meeting of Shareholders at 3:30 PM CDT. |
| December 6, 2024 | Deadline for shareholders to submit proposals for inclusion in the 2025 proxy statement. |
| March 10, 2025 | Deadline for shareholders to provide notice of intent to solicit proxies in support of director nominees. |
Keywords
Annual Meeting, Shareholders, Proxy Statement, Board of Directors, Executive Compensation, Director Election, Corporate Governance, National HealthCare Corporation, NHC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.